Rifamycin-induced lupus syndrome.
Berning
S E
SE
Iseman
M D
MD
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D000904:Antibiotics, Antitubercular / Q000009:adverse effects; D000974:Antibodies, Antinuclear / Q000032:analysis; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009164:Mycobacterium Infections / Q000188:drug therapy; D017828:Rifabutin / Q000009:adverse effects; D012294:Rifamycins / Q000009:adverse effects*; D013577:Syndrome
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D000974:Antibodies, Antinuclear; D012294:Rifamycins; D017828:Rifabutin